Eagle Pharmaceuticals
EGRX
#9769
Rank
ยฃ9.78 M
Marketcap
ยฃ0.75
Share price
5.56%
Change (1 day)
-89.45%
Change (1 year)

Revenue for Eagle Pharmaceuticals (EGRX)

Revenue in 2023 (TTM): ยฃ0.21 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ0.20 Billion. In 2022 the company made a revenue of ยฃ0.26 Billion an increase over the revenue in the year 2021 that were of ยฃ0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eagle Pharmaceuticals from 2013 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ0.21 B-18.25%
2022 ยฃ0.26 B105.93%
2021 ยฃ0.12 B-7.76%
2020 ยฃ0.13 B-7.77%
2019 ยฃ0.14 B-11.1%
2018 ยฃ0.16 B-4.05%
2017 ยฃ0.17 B14.05%
2016 ยฃ0.15 B243.61%
2015 ยฃ44.69 M262.25%
2014 ยฃ12.33 M15.05%
2013 ยฃ10.72 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ69.68 B 33,949.96%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.98 B 15,529.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ39.68 B 19,290.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ12.94 B 6,224.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ25.85 B 12,532.06%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.47 B 15,766.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.69 B 18,317.71%๐Ÿ‡บ๐Ÿ‡ธ USA